against symptomatic COVID-19 cases - for brands name products

China’s Sinovac vaccine 50.7% effective against symptomatic COVID-19 cases

Post author:guestcn
Post published:April 12, 2021
Post category:China News Novel Coronavirus
Post comments:0 Comments

CoronaVac, an inactivated COVID-19 vaccine developed by China's Sinovac Biotech Ltd., was shown to be 50.7% effective against symptomatic COVID-19 cases, according to new trial results revealed by Brazil's state-run Butantan Institute on Sunday.